NewHold Investment Corp. III, a publicly traded special purpose acquisition company (SPAC), announced on September 17, 2026, that its shareholders have approved the previously announced business combination with newcleo plc. The approval was secured at the company’s Extraordinary General Meeting held on that date.
Shareholders voted on two primary proposals related to the transaction. The first proposal, regarding the approval of the Business Combination Agreement, received 19,986,437 votes in favor, 1,286,410 against, and 2 abstentions. The second proposal, concerning the plan of merger, received 19,986,439 votes in favor and 1,286,410 against, with zero abstentions.
According to the filing, approximately 93.4% of the votes cast at the meeting supported the Business Combination proposal. The transaction is expected to close on or about Monday, September 21, 2026, upon the satisfaction of customary closing conditions.
Following the closing, the combined entity will operate as newcleo plc. The company’s shares of common stock and warrants are scheduled to begin trading on the Nasdaq Stock Market LLC under the symbols "NWCL" and "NWCLW," respectively, on or about Tuesday, September 22, 2026.
newcleo is a nuclear energy company focused on developing advanced modular reactors cooled by liquid lead and facilities to produce nuclear fuel from recycled waste. The company was founded by physicist-entrepreneur Stefano Buono following the sale of Advanced Accelerator Applications to Novartis for approximately $3.9 billion. newcleo reports having approximately $800 million in private funding and over 900 employees across Europe and the United States.
